Rx Re-Importation Bill Impact Could Be Limited By Canadian Export Laws
• By The Pink Sheet
Canadian export regulations would limit the impact of pharmaceutical re-importation proposals pending in Congress, a former Canadian official said at a July 24 American Enterprise Institute conference in Washington, D.C.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
